fosphenytoin
Generic: fosphenytoin sodium
Labeler: fresenius kabi usa, llcDrug Facts
Product Profile
Brand Name
fosphenytoin
Generic Name
fosphenytoin sodium
Labeler
fresenius kabi usa, llc
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
fosphenytoin sodium 50 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
63323-403
Product ID
63323-403_84385df0-4793-47d2-8e49-5c84668a0ba3
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA078052
Listing Expiration
2026-12-31
Marketing Start
2009-12-14
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
63323403
Hyphenated Format
63323-403
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
fosphenytoin (source: ndc)
Generic Name
fosphenytoin sodium (source: ndc)
Application Number
ANDA078052 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 50 mg/mL
Packaging
- 25 VIAL in 1 TRAY (63323-403-02) / 2 mL in 1 VIAL (63323-403-01)
- 10 VIAL in 1 TRAY (63323-403-10) / 10 mL in 1 VIAL (63323-403-04)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "84385df0-4793-47d2-8e49-5c84668a0ba3", "openfda": {"upc": ["0363323403010", "0363323403041"], "unii": ["7VLR55452Z"], "rxcui": ["1670195", "1670200"], "spl_set_id": ["b60c9c82-e5c7-4e05-98c7-5bbba4af04b2"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL in 1 TRAY (63323-403-02) / 2 mL in 1 VIAL (63323-403-01)", "package_ndc": "63323-403-02", "marketing_start_date": "20091214"}, {"sample": false, "description": "10 VIAL in 1 TRAY (63323-403-10) / 10 mL in 1 VIAL (63323-403-04)", "package_ndc": "63323-403-10", "marketing_start_date": "20091214"}], "brand_name": "Fosphenytoin", "product_id": "63323-403_84385df0-4793-47d2-8e49-5c84668a0ba3", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Anti-epileptic Agent [EPC]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "63323-403", "generic_name": "FOSPHENYTOIN SODIUM", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fosphenytoin", "active_ingredients": [{"name": "FOSPHENYTOIN SODIUM", "strength": "50 mg/mL"}], "application_number": "ANDA078052", "marketing_category": "ANDA", "marketing_start_date": "20091214", "listing_expiration_date": "20261231"}